Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.

ABSTRACT:

Objective

To compare the model-predicted benefits, harms, and cost-effectiveness of cytology, cotesting, and primary HPV screening in US women with HIV (WWH).

Design

We adapted a previously published Markov decision model to simulate a cohort of US WWH.

Setting

United States.

Subjects, participants

A hypothetical inception cohort of WWH.

Intervention

We simulated five screening strategies all assumed the same strategy of cytology with HPV triage for ASCUS for women aged 21-29 years. The different strategies noted are for women aged 30 and older as the following: continue cytology with HPV triage, cotesting with repeat cotesting triage, cotesting with HPV16/18 genotyping triage, primary hrHPV testing with cytology triage, and primary hrHPV testing with HP

SUBMITTER: Zhao R 

PROVIDER: S-EPMC11666405 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature